Literature DB >> 26656648

Clinical utility of genetic and genomic services: context matters.

W David Dotson1, M Scott Bowen1, Katherine Kolor1, Muin J Khoury1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26656648      PMCID： PMC4902786          DOI： 10.1038/gim.2015.153

Source DB:  PubMed          Journal:  Genet Med        ISSN： 1098-3600            Impact factor:   8.822


× No keyword cloud information.
  8 in total

Review 1.  Cascade screening: whose information is it anyway?

Authors:  Guido de Wert
Journal:  Eur J Hum Genet       Date:  2005-04       Impact factor: 4.246

2.  Outcomes of interest in evidence-based evaluations of genetic tests.

Authors:  Jeffrey R Botkin; Steven M Teutsch; Celia I Kaye; Maxine Hayes; James E Haddow; Linda A Bradley; Kathleen Szegda; W David Dotson
Journal:  Genet Med       Date:  2010-04       Impact factor: 8.822

3.  Committee report: Method for evaluating conditions nominated for population-based screening of newborns and children.

Authors:  Ned Calonge; Nancy S Green; Piero Rinaldo; Michele Lloyd-Puryear; Denise Dougherty; Coleen Boyle; Michael Watson; Tracy Trotter; Sharon F Terry; R Rodney Howell
Journal:  Genet Med       Date:  2010-03       Impact factor: 8.822

4.  Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives.

Authors: 
Journal:  Genet Med       Date:  2009-01       Impact factor: 8.822

5.  The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Initiative: methods of the EGAPP Working Group.

Authors:  Steven M Teutsch; Linda A Bradley; Glenn E Palomaki; James E Haddow; Margaret Piper; Ned Calonge; W David Dotson; Michael P Douglas; Alfred O Berg
Journal:  Genet Med       Date:  2009-01       Impact factor: 8.822

6.  Clinical utility of genetic and genomic services: a position statement of the American College of Medical Genetics and Genomics.

Authors: 
Journal:  Genet Med       Date:  2015-03-12       Impact factor: 8.822

7.  How can the evaluation of genetic tests be enhanced? Lessons learned from the ACCE framework and evaluating genetic tests in the United Kingdom.

Authors:  Simon Sanderson; Ron Zimmern; Mark Kroese; Julian Higgins; Christine Patch; Jon Emery
Journal:  Genet Med       Date:  2005-09       Impact factor: 8.822

Review 8.  Achieving the "triple aim" for inborn errors of metabolism: a review of challenges to outcomes research and presentation of a new practice-based evidence framework.

Authors:  Beth K Potter; Pranesh Chakraborty; Jonathan B Kronick; Kumanan Wilson; Doug Coyle; Annette Feigenbaum; Michael T Geraghty; Maria D Karaceper; Julian Little; Aizeddin Mhanni; John J Mitchell; Komudi Siriwardena; Brenda J Wilson; Ania Syrowatka
Journal:  Genet Med       Date:  2012-12-06       Impact factor: 8.822
  8 in total
  6 in total

1.  Integrating Genomics into Healthcare: A Global Responsibility.

Authors:  Zornitza Stark; Lena Dolman; Teri A Manolio; Brad Ozenberger; Sue L Hill; Mark J Caulfied; Yves Levy; David Glazer; Julia Wilson; Mark Lawler; Tiffany Boughtwood; Jeffrey Braithwaite; Peter Goodhand; Ewan Birney; Kathryn N North
Journal:  Am J Hum Genet       Date:  2019-01-03       Impact factor: 11.025

2.  EXAMINING EVIDENCE IN U.S. PAYER COVERAGE POLICIES FOR MULTI-GENE PANELS AND SEQUENCING TESTS.

Authors:  James D Chambers; Cayla J Saret; Jordan E Anderson; Patricia A Deverka; Michael P Douglas; Kathryn A Phillips
Journal:  Int J Technol Assess Health Care       Date:  2017-10-25       Impact factor: 2.188

Review 3.  Genomics and Epigenomics of Congenital Heart Defects: Expert Review and Lessons Learned in Africa.

Authors:  Nicholas Ekow Thomford; Kevin Dzobo; Nana Akyaa Yao; Emile Chimusa; Jonathan Evans; Emmanuel Okai; Paul Kruszka; Maximilian Muenke; Gordon Awandare; Ambroise Wonkam; Collet Dandara
Journal:  OMICS       Date:  2018-05

Review 4.  Review of the Reported Measures of Clinical Validity and Clinical Utility as Arguments for the Implementation of Pharmacogenetic Testing: A Case Study of Statin-Induced Muscle Toxicity.

Authors:  Marleen E Jansen; T Rigter; W Rodenburg; T M C Fleur; E J F Houwink; M Weda; Martina C Cornel
Journal:  Front Pharmacol       Date:  2017-08-23       Impact factor: 5.810

5.  A proposal of a new evaluation framework towards implementation of genetic tests.

Authors:  Erica Pitini; Elvira D'Andrea; Corrado De Vito; Annalisa Rosso; Brigid Unim; Carolina Marzuillo; Antonio Federici; Emilio Di Maria; Paolo Villari
Journal:  PLoS One       Date:  2019-08-05       Impact factor: 3.240

Review 6.  The influence of social determinants of health on the genetic diagnostic odyssey: who remains undiagnosed, why, and to what effect?

Authors:  Yarden S Fraiman; Monica H Wojcik
Journal:  Pediatr Res       Date:  2020-09-15       Impact factor: 3.756
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.